Sun Z, Chen H, Li C, Yang H, Ling J, Chang A
Eur Arch Otorhinolaryngol. 2025; .
PMID: 39757267
DOI: 10.1007/s00405-024-09176-w.
Tran N, Truong A, Nguyen D, Dang T
Adv Sci (Weinh). 2024; 12(5):e2309709.
PMID: 39630111
PMC: 11792001.
DOI: 10.1002/advs.202309709.
Al-Essa M, Al-Qudah T, Al Hadidi A, Alshubbak N
Biomed Res Int. 2024; 2024:7919329.
PMID: 39371248
PMC: 11452246.
DOI: 10.1155/2024/7919329.
Zhou D, Fan X, Xie S, Lu M, Gao L, Zhang R
Oncol Lett. 2024; 28(2):384.
PMID: 38966578
PMC: 11222915.
DOI: 10.3892/ol.2024.14517.
Miskin R, DiPersio C
Am J Physiol Cell Physiol. 2024; 326(5):C1308-C1319.
PMID: 38497112
PMC: 11371326.
DOI: 10.1152/ajpcell.00128.2024.
Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer.
Synelnyk T, Vovk T, Halenova T, Tytarenko V, Raksha N, Savchuk O
Front Med (Lausanne). 2023; 10:1276882.
PMID: 38034543
PMC: 10685322.
DOI: 10.3389/fmed.2023.1276882.
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer.
Chen Y, Li B, Wang J, Wang Y, Luo S, Lin R
BMC Cancer. 2023; 23(1):1122.
PMID: 37978366
PMC: 10657128.
DOI: 10.1186/s12885-023-11550-6.
Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas.
Hey G, Rao R, Carter A, Reddy A, Valle D, Patel A
J Pers Med. 2023; 13(5).
PMID: 37241023
PMC: 10224160.
DOI: 10.3390/jpm13050853.
Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders.
Senjor E, Kos J, Perisic Nanut M
Biomedicines. 2023; 11(2).
PMID: 36831012
PMC: 9953096.
DOI: 10.3390/biomedicines11020476.
The role and regulation of Maf proteins in cancer.
Deng Y, Lu L, Zhang H, Fu Y, Liu T, Chen Y
Biomark Res. 2023; 11(1):17.
PMID: 36750911
PMC: 9903618.
DOI: 10.1186/s40364-023-00457-w.
Proteome derangement in malignant epithelial cells and its stroma following exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Marshall K, Twum Y, Gao W
Arch Toxicol. 2022; 97(3):711-720.
PMID: 36434399
PMC: 10071504.
DOI: 10.1007/s00204-022-03426-8.
Tumor-derived exosomal HOTAIRM1 regulates SPON2 in CAFs to promote progression of lung adenocarcinoma.
Chen Z, Bian C, Huang J, Li X, Chen L, Xie X
Discov Oncol. 2022; 13(1):92.
PMID: 36153414
PMC: 9509512.
DOI: 10.1007/s12672-022-00553-7.
Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.
Dettling D, Kwok E, Quach L, Datt A, Degenhardt J, Panchal A
J Immunother Cancer. 2022; 10(6).
PMID: 35728872
PMC: 9214390.
DOI: 10.1136/jitc-2021-004336.
Role of Serine Proteases at the Tumor-Stroma Interface.
Tagirasa R, Yoo E
Front Immunol. 2022; 13:832418.
PMID: 35222418
PMC: 8873516.
DOI: 10.3389/fimmu.2022.832418.
Helicobacter pylori and gastric cancer: a lysosomal protease perspective.
Soond S, Zamyatnin Jr A
Gastric Cancer. 2021; 25(2):306-324.
PMID: 34918208
PMC: 8882093.
DOI: 10.1007/s10120-021-01272-8.
Epidermal Integrin α3β1 Regulates Tumor-Derived Proteases BMP-1, Matrix Metalloprotease-9, and Matrix Metalloprotease-3.
Longmate W, Miskin R, Van De Water L, DiPersio C
JID Innov. 2021; 1(2):100017.
PMID: 34909716
PMC: 8659409.
DOI: 10.1016/j.xjidi.2021.100017.
Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.
Habic A, Novak M, Majc B, Lah Turnsek T, Breznik B
J Histochem Cytochem. 2021; 69(12):775-794.
PMID: 34310223
PMC: 8647633.
DOI: 10.1369/00221554211035192.
An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5.
Lah Turnsek T, Jiao X, Novak M, Jammula S, Cicero G, Ashton A
Int J Mol Sci. 2021; 22(9).
PMID: 33923334
PMC: 8123168.
DOI: 10.3390/ijms22094464.
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.
Majc B, Novak M, Kopitar-Jerala N, Jewett A, Breznik B
Cells. 2021; 10(2).
PMID: 33572835
PMC: 7912469.
DOI: 10.3390/cells10020265.
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.
Meskyte E, Keskas S, Ciribilli Y
Int J Mol Sci. 2020; 21(20).
PMID: 33081056
PMC: 7589112.
DOI: 10.3390/ijms21207710.